Evidence map›Paper›PMID 34709749›Full record

ArticleClinical and translational medicine2021

KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer.

Ho Tsoi, Ellen Ps Man, Man-Hong Leung, Ka-Chun Mok, Ka-Man Chau, Lai-San Wong, Wing-Lok Chan, Sum-Yin Chan, Mai-Yee Luk, Cheuk-Nam Cheng and 1 more

Open access · goldAbstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Ho TsoiDepartment of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Ellen Ps ManDepartment of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Man-Hong LeungDepartment of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Ka-Chun MokDepartment of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Ka-Man ChauDepartment of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Lai-San WongDepartment of Clinical Oncology, Queen Mary Hospital, Hong Kong, China.
Wing-Lok ChanDepartment of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, China.
Sum-Yin ChanDepartment of Clinical Oncology, Queen Mary Hospital, Hong Kong, China.
Mai-Yee LukDepartment of Clinical Oncology, Queen Mary Hospital, Hong Kong, China.
Cheuk-Nam ChengDepartment of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Ui-Soon KhooDepartment of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0003-2200-7505
University of Hong Kong · HKQueen Mary Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Active Transport, Cell Nucleusalpha KaryopherinsBreast NeoplasmsDrug ResistanceFemaleHumansNuclear Receptor Co-Repressor 2Tamoxifenalpha KaryopherinsKPNA1 protein, humanNCOR2 protein, humanNuclear Receptor Co-Repressor 2Tamoxifen

Identifiers

PMID34709749
PMCPMC8506633
OpenAlexW3207047373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.